NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced that new findings from its pivotal Phase 3 SIERRA trial for Iomab-B (Iodine-131 apamistamab) that support its Iomab-ACT program for lymphodepletion for CAR-T and adoptive cell therapies has been accepted for presentation at the 2019 Americ

PHILADELPHIA, Nov. 6, 2019 /PRNewswire/ -- EIR Healthcare, the award-winning modular innovation firm bringing efficient industrial practices to healthcare, real estate and hospitality, annou

WALNUT CREEK, Calif., Nov. 6, 2019 /PRNewswire/ -- Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today unveiled its newly enhanced Expert-Driven, Data-Guided (EDDG) platform. The EDDG platform uses proprietary case management data from Paradigm's nearly 30 years of experience serving the workers' compen

CAMBRIDGE, Mass., Nov. 6, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that an abstract for the ongoing Phase 2 PIONEER clinical trial evaluating avapritinib for the treatment of indolent and smoldering systemic mastocyt

BALTIMORE, Nov. 6, 2019 /PRNewswire/ -- Thermo Fisher Scientific announced the launch of its

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, prostate and colorectal, today announced that data from its completed Phase

INDIANAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that multiple abstracts from its LOXO-305 program have been accepted for presentation at the 61st American Society of Hematology Annual Meeting and Exposition to be held December 7-10, 2019 in Orlando, Florida. LOXO-3

ROCK HILL, S.C., Nov. 6, 2019 /PRNewswire/ -- Today, 3

ORLANDO, Fla., Nov. 6, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime and Duquesne University School of Pharmacy recently announced results from research analyzing data from cystic fibrosis (CF) patients prescribed cystic fibrosis transmembrane conductance regulator (CFTR) modulator medications. Researchers wanted to understand if p